Abstract |
Insulin-like growth factor-I receptor (IGF-IR) overexpression may play a role in prostate cancer progression. We found previously that, in prostate cancer cells, IGF-IR is up-regulated by both androgens and estrogens via a nongenotropic pathway. We now show that, in prostate cancer cells, stimulation with either androgens or estrogens up-regulates IGF-IR by inducing cyclic AMP response element-binding protein (CREB) activation. Both sex steroids phosphorylated CREB at Ser(133) in a dose-dependent manner in androgen receptor (AR)-positive LNCaP cells, whereas only estrogens phosphorylated CREB in AR-negative PC3 cells. CREB phosphorylation involved c-Src-dependent extracellular signal-regulated kinase 1/2 activation, but not protein kinase A, protein kinase C, or calmodulin-dependent kinase II, and occurred also in cells transfected with AR or estrogen receptor mutants that do not localize into the nucleus. CREB silencing abrogated IGF-IR up-regulation and promoter activation. We also showed that CREB binds to IGF-IR promoter region and identified the relevant CREB-binding site at the 5'-untranslated region fragment of IGF-IR promoter. In conclusion, we describe a novel mechanism of IGF-IR up-regulation and promoter activity by CREB activation, induced by sex steroids, through a nongenotropic signaling.
|
Authors | Marco Genua, Giuseppe Pandini, Diego Sisci, Gabriella Castoria, Marcello Maggiolini, Riccardo Vigneri, Antonino Belfiore |
Journal | Cancer research
(Cancer Res)
Vol. 69
Issue 18
Pg. 7270-7
(Sep 15 2009)
ISSN: 1538-7445 [Electronic] United States |
PMID | 19738069
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Estrogen Receptor alpha
- Estrogen Receptor beta
- Metribolone
- Estradiol
- CREB-Binding Protein
- CREBBP protein, human
- Receptor, IGF Type 1
|
Topics |
- CREB-Binding Protein
(metabolism)
- Cell Line, Tumor
- Estradiol
(pharmacology)
- Estrogen Receptor alpha
(genetics, metabolism)
- Estrogen Receptor beta
(genetics, metabolism)
- Humans
- Male
- Metribolone
(pharmacology)
- Mutagenesis, Site-Directed
- Phosphorylation
- Promoter Regions, Genetic
- Prostatic Neoplasms
(genetics, metabolism)
- Receptor, IGF Type 1
(genetics, metabolism)
- Transfection
- Up-Regulation
(drug effects)
|